世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

静脈注射液の世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2025-2031年

静脈注射液の世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2025-2031年


Global Intravenous Solutions Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

2024年の点滴ソリューションの世界市場規模は1億2420万米ドルと推定され、2031年には年平均成長率6.3%で約1億8930万米ドルに達すると予測されている。 静脈内ソリューションは、液体物質を静脈に直接注入するこ... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2025年3月28日 US$5,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

2024年の点滴ソリューションの世界市場規模は1億2420万米ドルと推定され、2031年には年平均成長率6.3%で約1億8930万米ドルに達すると予測されている。
静脈内ソリューションは、液体物質を静脈に直接注入することである。静脈内投与される治療薬は、しばしば特殊医薬品の指定に含まれる。点滴は一般的に点滴と呼ばれるが、これは多くの投与システムが点滴室を採用しているためであり、これにより血液中に空気が入ること(空気塞栓症)を防ぎ、流量を推定することができる。
世界の点滴ソリューションの主要プレーヤーには、バクスター、Kelun Group、Fresenius Kabiなどが含まれる。世界のトップ3メーカーが35%以上のシェアを占めている。
アジア太平洋地域が45%以上のシェアで最大の市場であり、次いでヨーロッパ、北米が40%以上のシェアを占めている。
製品別では、晶析剤が最大のセグメントで、75%以上のシェアを占めている。また、用途別では、輸液が最も多く、次いで栄養輸液などとなっている。

レポートの範囲
本レポートは、点滴液の世界市場を定量的・定性的分析の両面から包括的に紹介し、読者が事業/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、点滴液に関する十分な情報に基づいたビジネス上の意思決定を行えるようにすることを目的としています。

点滴ソリューションの市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データを考慮し、販売量(百万単位)と収益(百万ドル)で提供されます。本レポートでは、世界の点滴液市場を包括的に区分しています。製品タイプ別、用途別、プレイヤー別の地域別市場規模も掲載しています。
市場のより詳細な理解のために、競合状況、主要競合企業のプロフィール、それぞれの市場ランクを掲載しています。また、技術動向や新製品開発についても論じています。
本レポートは、企業別、タイプ別、用途別、地域別など、さまざまなセグメントにわたる市場全体とサブセグメントの収益、販売量、平均価格に関する情報を提供することで、本市場における点滴ソリューションメーカー、新規参入企業、産業チェーン関連企業の助けとなることでしょう。

企業別
バクスター
ケルングループ
フレゼニウス・カビ
大塚製薬
ICUメディカル
フレゼニウス・カビ
JWライフサイエンス
B.ブラウン・メルサンゲン
タイプ別セグメント
クリスタロイド
コロイド
その他
用途別セグメント
基礎輸液
栄養輸液
その他
地域別
北米
米国
カナダ
アジア太平洋
中国
日本
韓国
インド
東南アジア
オーストラリア
その他のアジア太平洋地域
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他のヨーロッパ
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他のMEA

各章の概要
第1章: レポートのスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章:点滴静注液の販売(消費)、収益(世界・地域レベル各地域と主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場空間を紹介しています。
第3章:静脈注射液メーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析。
第4章:主要メーカーのプロフィールを提供し、製品の説明と仕様、点滴ソリューションの売上高、収益、価格、粗利益率、地域別、タイプ別、用途別の売上高、最近の開発など、市場の主要企業の基本状況を詳しく紹介する。
第5章:種類別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。
第6章:用途別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第7章:北米:タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章:APAC:タイプ別、用途別、国別、セグメント別の売上高と収益。
第9章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。
第10章:ラテンアメリカ:タイプ別、用途別、国別、セグメント別の売上高と収益。
第11章:中東・アフリカ:タイプ別、用途別、国別、セグメント別の売上高、収益
第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。
第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第14章:調査結果と結論。


ページTOPに戻る


目次

1 Study Coverage
1.1 Intravenous Solutions Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Solutions Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Intravenous Solutions Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Basic IV Solutions
1.3.3 Nutrient Infusion Solution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravenous Solutions Market Size Estimates and Forecasts
2.1.1 Global Intravenous Solutions Revenue 2020-2031
2.1.2 Global Intravenous Solutions Sales 2020-2031
2.2 Intravenous Solutions Market Size by Region: 2024 Versus 2031
2.3 Intravenous Solutions Sales by Region (2020-2031)
2.3.1 Global Intravenous Solutions Sales by Region: 2020-2025
2.3.2 Global Intravenous Solutions Sales Forecast by Region (2026-2031)
2.3.3 Global Intravenous Solutions Sales Market Share by Region (2020-2031)
2.4 Intravenous Solutions Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Intravenous Solutions Revenue by Region: 2020-2025
2.4.2 Global Intravenous Solutions Revenue Forecast by Region (2026-2031)
2.4.3 Global Intravenous Solutions Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Intravenous Solutions Sales by Type (2020-2031)
3.1.1.1 Global Intravenous Solutions Sales Volume by Type (2020-2031)
3.1.1.2 Global Intravenous Solutions Sales Market Share by Type (2020-2031)
3.1.2 Global Intravenous Solutions Revenue by Type (2020-2031)
3.1.2.1 Global Intravenous Solutions Revenue by Type (2020-2031)
3.1.2.2 Global Intravenous Solutions Revenue Market Share by Type (2020-2031)
3.1.3 Intravenous Solutions Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Intravenous Solutions Sales by Application (2020-2031)
3.2.1.1 Global Intravenous Solutions Sales Volume by Application (2020-2031)
3.2.1.2 Global Intravenous Solutions Sales Market Share by Application (2020-2031)
3.2.2 Global Intravenous Solutions Revenue by Application (2020-2031)
3.2.2.1 Global Intravenous Solutions Revenue by Application (2020-2031)
3.2.2.2 Global Intravenous Solutions Revenue Market Share by Application (2020-2031)
3.2.3 Intravenous Solutions Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Crystalloids of Intravenous Solutions Revenue Market Share by Application
3.3.2 Colloids of Intravenous Solutions Revenue Market Share by Application
3.3.3 Others of Intravenous Solutions Revenue Market Share by Application
4 Global Intravenous Solutions by Manufacturers
4.1 Global Top Intravenous Solutions Manufacturers by Sales (2020-2025)
4.1.1 Global Intravenous Solutions Sales by Manufacturer (2020-2025)
4.1.2 Global Intravenous Solutions Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Intravenous Solutions Manufacturers by Revenue (2020-2025)
4.2.1 Global Intravenous Solutions Revenue by Manufacturer (2020-2025)
4.2.2 Global Intravenous Solutions Revenue Share by Manufacturer (2020-2025)
4.3 Global Intravenous Solutions Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Intravenous Solutions Manufacturers Covered: Ranking by Revenue
4.4.2 Global Intravenous Solutions Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Intravenous Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Intravenous Solutions Manufacturing Base Distribution, Product Type
4.5.1 Intravenous Solutions Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Intravenous Solutions Market
4.5.3 Manufacturers Intravenous Solutions Product Type and Application
4.5.4 Crystalloids Market Sales of Intravenous Solutions by Manufacturer
4.5.5 Colloids Market Sales of Intravenous Solutions by Manufacturer
4.5.6 Others Market Sales of Intravenous Solutions by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Baxter
5.1.1 Baxter Company Information
5.1.2 Baxter Description, Business Overview
5.1.3 Baxter Intravenous Solutions Products Offered
5.1.4 Baxter Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Baxter Intravenous Solutions Sales by Product in 2024
5.1.6 Baxter Intravenous Solutions Sales by Application in 2024
5.1.7 Baxter Intravenous Solutions Sales by Geographic Area in 2024
5.1.8 Baxter Recent Developments
5.2 Kelun Group
5.2.1 Kelun Group Company Information
5.2.2 Kelun Group Description, Business Overview
5.2.3 Kelun Group Intravenous Solutions Products Offered
5.2.4 Kelun Group Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Kelun Group Intravenous Solutions Sales by Product in 2024
5.2.6 Kelun Group Intravenous Solutions Sales by Application in 2024
5.2.7 Kelun Group Intravenous Solutions Sales by Geographic Area in 2024
5.2.8 Kelun Group Recent Developments
5.3 Fresenius Kabi
5.3.1 Fresenius Kabi Company Information
5.3.2 Fresenius Kabi Description, Business Overview
5.3.3 Fresenius Kabi Intravenous Solutions Products Offered
5.3.4 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Fresenius Kabi Intravenous Solutions Sales by Product in 2024
5.3.6 Fresenius Kabi Intravenous Solutions Sales by Application in 2024
5.3.7 Fresenius Kabi Intravenous Solutions Sales by Geographic Area in 2024
5.3.8 Fresenius Kabi Recent Developments
5.4 Otsuka
5.4.1 Otsuka Company Information
5.4.2 Otsuka Description, Business Overview
5.4.3 Otsuka Intravenous Solutions Products Offered
5.4.4 Otsuka Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Otsuka Intravenous Solutions Sales by Product in 2024
5.4.6 Otsuka Intravenous Solutions Sales by Application in 2024
5.4.7 Otsuka Intravenous Solutions Sales by Geographic Area in 2024
5.4.8 Otsuka Recent Developments
5.5 ICU Medical
5.5.1 ICU Medical Company Information
5.5.2 ICU Medical Description, Business Overview
5.5.3 ICU Medical Intravenous Solutions Products Offered
5.5.4 ICU Medical Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.5.5 ICU Medical Intravenous Solutions Sales by Product in 2024
5.5.6 ICU Medical Intravenous Solutions Sales by Application in 2024
5.5.7 ICU Medical Intravenous Solutions Sales by Geographic Area in 2024
5.5.8 ICU Medical Recent Developments
5.6 Fresenius Kabi
5.6.1 Fresenius Kabi Company Information
5.6.2 Fresenius Kabi Description, Business Overview
5.6.3 Fresenius Kabi Intravenous Solutions Products Offered
5.6.4 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Fresenius Kabi Intravenous Solutions Sales by Product in 2024
5.6.6 Fresenius Kabi Intravenous Solutions Sales by Application in 2024
5.6.7 Fresenius Kabi Intravenous Solutions Sales by Geographic Area in 2024
5.6.8 Fresenius Kabi Recent Developments
5.7 JW Life Science
5.7.1 JW Life Science Company Information
5.7.2 JW Life Science Description, Business Overview
5.7.3 JW Life Science Intravenous Solutions Products Offered
5.7.4 JW Life Science Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.7.5 JW Life Science Intravenous Solutions Sales by Product in 2024
5.7.6 JW Life Science Intravenous Solutions Sales by Application in 2024
5.7.7 JW Life Science Intravenous Solutions Sales by Geographic Area in 2024
5.7.8 JW Life Science Recent Developments
5.8 B. Braun Melsungen
5.8.1 B. Braun Melsungen Company Information
5.8.2 B. Braun Melsungen Description, Business Overview
5.8.3 B. Braun Melsungen Intravenous Solutions Products Offered
5.8.4 B. Braun Melsungen Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.8.5 B. Braun Melsungen Intravenous Solutions Sales by Product in 2024
5.8.6 B. Braun Melsungen Intravenous Solutions Sales by Application in 2024
5.8.7 B. Braun Melsungen Intravenous Solutions Sales by Geographic Area in 2024
5.8.8 B. Braun Melsungen Recent Developments
6 North America
6.1 North America Intravenous Solutions Market Size YoY Growth 2020-2031
6.2 North America Intravenous Solutions Market Facts & Figures by Country
6.2.1 North America Intravenous Solutions Sales by Country (2020-2031)
6.2.2 North America Intravenous Solutions Revenue by Country (2020-2031)
6.3 North America Intravenous Solutions Sales by Type (2020-2025)
6.4 North America Intravenous Solutions Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Intravenous Solutions Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Intravenous Solutions Market Facts & Figures by Region
7.2.1 Asia-Pacific Intravenous Solutions Sales by Region (2020-2031)
7.2.2 Asia-Pacific Intravenous Solutions Revenue by Region (2020-2031)
7.3 Asia-Pacific Intravenous Solutions Sales by Type (2020-2025)
7.4 Asia-Pacific Intravenous Solutions Sales by Application (2020-2025)
8 Europe
8.1 Europe Intravenous Solutions Market Size YoY Growth 2020-2031
8.2 Europe Intravenous Solutions Market Facts & Figures by Country
8.2.1 Europe Intravenous Solutions Sales by Country (2020-2031)
8.2.2 Europe Intravenous Solutions Revenue by Country (2020-2031)
8.3 Europe Intravenous Solutions Sales by Type (2020-2025)
8.4 Europe Intravenous Solutions Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Intravenous Solutions Market Size YoY Growth 2020-2031
9.2 Latin America Intravenous Solutions Market Facts & Figures by Country
9.2.1 Latin America Intravenous Solutions Sales by Country (2020-2031)
9.2.2 Latin America Intravenous Solutions Revenue by Country (2020-2031)
9.3 Latin America Intravenous Solutions Sales by Type (2020-2025)
9.4 Latin America Intravenous Solutions Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Intravenous Solutions Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Intravenous Solutions Market Facts & Figures by Country
10.2.1 Middle East and Africa Intravenous Solutions Sales by Country (2020-2031)
10.2.2 Middle East and Africa Intravenous Solutions Revenue by Country (2020-2031)
10.3 Middle East and Africa Intravenous Solutions Sales by Type (2020-2025)
10.4 Middle East and Africa Intravenous Solutions Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Intravenous Solutions Supply Chain Analysis
11.2 Intravenous Solutions Key Raw Materials and Upstream Suppliers
11.3 Intravenous Solutions Clients Analysis
11.4 Intravenous Solutions Sales Channel and Sales Model Analysis
11.4.1 Intravenous Solutions Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Intravenous Solutions Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Intravenous Solutions Distributors
12 Intravenous Solutions Market Dynamics
12.1 Intravenous Solutions Industry Trends
12.2 Intravenous Solutions Market Drivers
12.3 Intravenous Solutions Market Challenges
12.4 Intravenous Solutions Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る


 

Summary

In 2024, the global market size of Intravenous Solutions was estimated to be worth US$ 12420 million and is forecast to reach approximately US$ 18930 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Intravenous Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Solutions.

The Intravenous Solutions market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Solutions manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

By Company
Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
Fresenius Kabi
JW Life Science
B. Braun Melsungen
Segment by Type
Crystalloids
Colloids
Others
Segment by Application
Basic IV Solutions
Nutrient Infusion Solution
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intravenous Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Intravenous Solutions manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Solutions sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Intravenous Solutions Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Solutions Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Intravenous Solutions Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Basic IV Solutions
1.3.3 Nutrient Infusion Solution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravenous Solutions Market Size Estimates and Forecasts
2.1.1 Global Intravenous Solutions Revenue 2020-2031
2.1.2 Global Intravenous Solutions Sales 2020-2031
2.2 Intravenous Solutions Market Size by Region: 2024 Versus 2031
2.3 Intravenous Solutions Sales by Region (2020-2031)
2.3.1 Global Intravenous Solutions Sales by Region: 2020-2025
2.3.2 Global Intravenous Solutions Sales Forecast by Region (2026-2031)
2.3.3 Global Intravenous Solutions Sales Market Share by Region (2020-2031)
2.4 Intravenous Solutions Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Intravenous Solutions Revenue by Region: 2020-2025
2.4.2 Global Intravenous Solutions Revenue Forecast by Region (2026-2031)
2.4.3 Global Intravenous Solutions Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Intravenous Solutions Sales by Type (2020-2031)
3.1.1.1 Global Intravenous Solutions Sales Volume by Type (2020-2031)
3.1.1.2 Global Intravenous Solutions Sales Market Share by Type (2020-2031)
3.1.2 Global Intravenous Solutions Revenue by Type (2020-2031)
3.1.2.1 Global Intravenous Solutions Revenue by Type (2020-2031)
3.1.2.2 Global Intravenous Solutions Revenue Market Share by Type (2020-2031)
3.1.3 Intravenous Solutions Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Intravenous Solutions Sales by Application (2020-2031)
3.2.1.1 Global Intravenous Solutions Sales Volume by Application (2020-2031)
3.2.1.2 Global Intravenous Solutions Sales Market Share by Application (2020-2031)
3.2.2 Global Intravenous Solutions Revenue by Application (2020-2031)
3.2.2.1 Global Intravenous Solutions Revenue by Application (2020-2031)
3.2.2.2 Global Intravenous Solutions Revenue Market Share by Application (2020-2031)
3.2.3 Intravenous Solutions Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Crystalloids of Intravenous Solutions Revenue Market Share by Application
3.3.2 Colloids of Intravenous Solutions Revenue Market Share by Application
3.3.3 Others of Intravenous Solutions Revenue Market Share by Application
4 Global Intravenous Solutions by Manufacturers
4.1 Global Top Intravenous Solutions Manufacturers by Sales (2020-2025)
4.1.1 Global Intravenous Solutions Sales by Manufacturer (2020-2025)
4.1.2 Global Intravenous Solutions Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Intravenous Solutions Manufacturers by Revenue (2020-2025)
4.2.1 Global Intravenous Solutions Revenue by Manufacturer (2020-2025)
4.2.2 Global Intravenous Solutions Revenue Share by Manufacturer (2020-2025)
4.3 Global Intravenous Solutions Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Intravenous Solutions Manufacturers Covered: Ranking by Revenue
4.4.2 Global Intravenous Solutions Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Intravenous Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Intravenous Solutions Manufacturing Base Distribution, Product Type
4.5.1 Intravenous Solutions Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Intravenous Solutions Market
4.5.3 Manufacturers Intravenous Solutions Product Type and Application
4.5.4 Crystalloids Market Sales of Intravenous Solutions by Manufacturer
4.5.5 Colloids Market Sales of Intravenous Solutions by Manufacturer
4.5.6 Others Market Sales of Intravenous Solutions by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Baxter
5.1.1 Baxter Company Information
5.1.2 Baxter Description, Business Overview
5.1.3 Baxter Intravenous Solutions Products Offered
5.1.4 Baxter Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Baxter Intravenous Solutions Sales by Product in 2024
5.1.6 Baxter Intravenous Solutions Sales by Application in 2024
5.1.7 Baxter Intravenous Solutions Sales by Geographic Area in 2024
5.1.8 Baxter Recent Developments
5.2 Kelun Group
5.2.1 Kelun Group Company Information
5.2.2 Kelun Group Description, Business Overview
5.2.3 Kelun Group Intravenous Solutions Products Offered
5.2.4 Kelun Group Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Kelun Group Intravenous Solutions Sales by Product in 2024
5.2.6 Kelun Group Intravenous Solutions Sales by Application in 2024
5.2.7 Kelun Group Intravenous Solutions Sales by Geographic Area in 2024
5.2.8 Kelun Group Recent Developments
5.3 Fresenius Kabi
5.3.1 Fresenius Kabi Company Information
5.3.2 Fresenius Kabi Description, Business Overview
5.3.3 Fresenius Kabi Intravenous Solutions Products Offered
5.3.4 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Fresenius Kabi Intravenous Solutions Sales by Product in 2024
5.3.6 Fresenius Kabi Intravenous Solutions Sales by Application in 2024
5.3.7 Fresenius Kabi Intravenous Solutions Sales by Geographic Area in 2024
5.3.8 Fresenius Kabi Recent Developments
5.4 Otsuka
5.4.1 Otsuka Company Information
5.4.2 Otsuka Description, Business Overview
5.4.3 Otsuka Intravenous Solutions Products Offered
5.4.4 Otsuka Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Otsuka Intravenous Solutions Sales by Product in 2024
5.4.6 Otsuka Intravenous Solutions Sales by Application in 2024
5.4.7 Otsuka Intravenous Solutions Sales by Geographic Area in 2024
5.4.8 Otsuka Recent Developments
5.5 ICU Medical
5.5.1 ICU Medical Company Information
5.5.2 ICU Medical Description, Business Overview
5.5.3 ICU Medical Intravenous Solutions Products Offered
5.5.4 ICU Medical Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.5.5 ICU Medical Intravenous Solutions Sales by Product in 2024
5.5.6 ICU Medical Intravenous Solutions Sales by Application in 2024
5.5.7 ICU Medical Intravenous Solutions Sales by Geographic Area in 2024
5.5.8 ICU Medical Recent Developments
5.6 Fresenius Kabi
5.6.1 Fresenius Kabi Company Information
5.6.2 Fresenius Kabi Description, Business Overview
5.6.3 Fresenius Kabi Intravenous Solutions Products Offered
5.6.4 Fresenius Kabi Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Fresenius Kabi Intravenous Solutions Sales by Product in 2024
5.6.6 Fresenius Kabi Intravenous Solutions Sales by Application in 2024
5.6.7 Fresenius Kabi Intravenous Solutions Sales by Geographic Area in 2024
5.6.8 Fresenius Kabi Recent Developments
5.7 JW Life Science
5.7.1 JW Life Science Company Information
5.7.2 JW Life Science Description, Business Overview
5.7.3 JW Life Science Intravenous Solutions Products Offered
5.7.4 JW Life Science Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.7.5 JW Life Science Intravenous Solutions Sales by Product in 2024
5.7.6 JW Life Science Intravenous Solutions Sales by Application in 2024
5.7.7 JW Life Science Intravenous Solutions Sales by Geographic Area in 2024
5.7.8 JW Life Science Recent Developments
5.8 B. Braun Melsungen
5.8.1 B. Braun Melsungen Company Information
5.8.2 B. Braun Melsungen Description, Business Overview
5.8.3 B. Braun Melsungen Intravenous Solutions Products Offered
5.8.4 B. Braun Melsungen Intravenous Solutions Sales, Revenue and Gross Margin (2020-2025)
5.8.5 B. Braun Melsungen Intravenous Solutions Sales by Product in 2024
5.8.6 B. Braun Melsungen Intravenous Solutions Sales by Application in 2024
5.8.7 B. Braun Melsungen Intravenous Solutions Sales by Geographic Area in 2024
5.8.8 B. Braun Melsungen Recent Developments
6 North America
6.1 North America Intravenous Solutions Market Size YoY Growth 2020-2031
6.2 North America Intravenous Solutions Market Facts & Figures by Country
6.2.1 North America Intravenous Solutions Sales by Country (2020-2031)
6.2.2 North America Intravenous Solutions Revenue by Country (2020-2031)
6.3 North America Intravenous Solutions Sales by Type (2020-2025)
6.4 North America Intravenous Solutions Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Intravenous Solutions Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Intravenous Solutions Market Facts & Figures by Region
7.2.1 Asia-Pacific Intravenous Solutions Sales by Region (2020-2031)
7.2.2 Asia-Pacific Intravenous Solutions Revenue by Region (2020-2031)
7.3 Asia-Pacific Intravenous Solutions Sales by Type (2020-2025)
7.4 Asia-Pacific Intravenous Solutions Sales by Application (2020-2025)
8 Europe
8.1 Europe Intravenous Solutions Market Size YoY Growth 2020-2031
8.2 Europe Intravenous Solutions Market Facts & Figures by Country
8.2.1 Europe Intravenous Solutions Sales by Country (2020-2031)
8.2.2 Europe Intravenous Solutions Revenue by Country (2020-2031)
8.3 Europe Intravenous Solutions Sales by Type (2020-2025)
8.4 Europe Intravenous Solutions Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Intravenous Solutions Market Size YoY Growth 2020-2031
9.2 Latin America Intravenous Solutions Market Facts & Figures by Country
9.2.1 Latin America Intravenous Solutions Sales by Country (2020-2031)
9.2.2 Latin America Intravenous Solutions Revenue by Country (2020-2031)
9.3 Latin America Intravenous Solutions Sales by Type (2020-2025)
9.4 Latin America Intravenous Solutions Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Intravenous Solutions Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Intravenous Solutions Market Facts & Figures by Country
10.2.1 Middle East and Africa Intravenous Solutions Sales by Country (2020-2031)
10.2.2 Middle East and Africa Intravenous Solutions Revenue by Country (2020-2031)
10.3 Middle East and Africa Intravenous Solutions Sales by Type (2020-2025)
10.4 Middle East and Africa Intravenous Solutions Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Intravenous Solutions Supply Chain Analysis
11.2 Intravenous Solutions Key Raw Materials and Upstream Suppliers
11.3 Intravenous Solutions Clients Analysis
11.4 Intravenous Solutions Sales Channel and Sales Model Analysis
11.4.1 Intravenous Solutions Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Intravenous Solutions Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Intravenous Solutions Distributors
12 Intravenous Solutions Market Dynamics
12.1 Intravenous Solutions Industry Trends
12.2 Intravenous Solutions Market Drivers
12.3 Intravenous Solutions Market Challenges
12.4 Intravenous Solutions Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(channel)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/04/04 10:27

147.03 円

163.01 円

195.36 円

ページTOPに戻る